1. Absence of HBsAg early in the course of fulminant hepatitis B: prevalence and prognostic value;lBernuau J; F, Dubois; T, Poynard,1982
2. Severe hepatic failure: a critical study of current therapy;Benhamou, J.P.; Rueff, B.; Sicot, C.,1972
3. Fulminant hepatic failure;Berk, P.D.; Popper, H.;Am J Gastroenterol,1978
4. Hepatitis B antigen (HBsAg) and/or antibodies (anti-HBs and antiHBc) in fulminant hepatitis: pathogenic and prognostic significance;Trepo, C.G.; Robert, D.; Motin, J.; Trepo, D.; Sepetjian, M.; Prince, A.M.;Gut,1976
5. Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B;Woolf, I.L.; El Sheik, N.; Cullens, H.;Br Med J,1976